alphaveSPARC₹196.80

Sun Pharma Advanced Research Company Ltd.

₹ CrorePeersSTAR SHILPAMED SUPRIYA THYROCARE RUBICON VIYASH YATHARTH PARKHOSPSMcap ₹6,386 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	107.4	98.7	85.2	85.2
+ Capital Work-in-Progress	1.3	0.6	0.5	0.5
+ Other Intangibles	0.2	0.1	0.1	0.1
+ Intangibles under Development	42.5	53.6	71.2	71.2
+ Other Non-current Financial Assets	25.5	26.1	28.7	28.7
Non-current Financial Assets	25.5	26.1	28.7	28.7
+ Deferred Tax Assets	1.3	2.3	2.3	2.3
+ Other Non-current Assets	67.6	128.0	120.4	120.4
Total Non-current Assets	245.7	309.3	308.4	308.4
Current Assets
+ Current Investments	1.8	0.0	0.0	0.0
+ Trade Receivables	15.5	16.1	8.3	8.3
+ Cash & Cash Equivalents	5.3	2.0	1.2	1.2
+ Other Bank Balances	150.0	0.0	0.0	0.0
+ Short-term Loans	0.2	0.2	0.2	0.2
+ Other Current Financial Assets	42.8	2.4	1.5	1.5
Current Financial Assets	215.7	20.5	11.1	11.1
+ Other Current Assets	53.7	5.7	1,845.9	1,845.9
Total Current Assets	269.4	26.2	1,862.4	1,862.4
Total Assets	515.0	335.5	2,170.9	2,170.9
Equity
+ Equity Share Capital	32.5	32.5	32.5	32.5
+ Other Equity / Reserves	93.3	-249.4	1,306.4	1,306.4
Equity — Owners of Parent	125.8	-217.0	1,338.8	1,338.8
Total Equity	125.8	-217.0	1,338.8	1,338.8
Liabilities
+ Borrowings — Non-current	0.0	100.0	0.0	0.0
+ Other Non-current Financial Liab	14.7	8.0	3.0	3.0
Non-current Financial Liabilities	14.7	108.0	3.0	3.0
+ Provisions — Non-current	6.1	7.7	12.3	12.3
+ Other Non-current Liabilities	103.5	62.6	62.6	62.6
Non-current Liabilities	124.2	178.2	78.0	78.0
+ Borrowings — Current	47.0	158.2	556.1	556.1
+ Trade Payables	142.3	113.9	97.2	97.2
+ Other Current Financial Liab	46.8	41.7	79.7	79.7
Current Financial Liabilities	236.1	313.8	733.0	733.0
+ Provisions — Current	12.2	7.5	12.9	12.9
+ Current Tax Liabilities	1.7	0.4	0.0	0.0
+ Other Current Liabilities	15.1	52.6	8.2	8.2
Current Liabilities	265.1	374.2	754.1	754.1
Total Liabilities	389.3	552.5	832.0	832.0
Total Equity & Liabilities	515.0	335.5	2,170.9	2,170.9
Assets — additional as-filed lines
+ Current Tax Assets	0.0	0.0	5.5	5.5
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	0.9	1.3	1.3
+ Dues to Other Creditors — Current	—	113.0	95.9	95.9

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.